The safety and efficacy of indobufen or aspirin combined with clopidogrel in patients with acute myocardial infarction after percutaneous coronary intervention-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The safety and efficacy of indobufen or aspirin combined with clopidogrel in patients with acute myocardial infarction after percutaneous coronary intervention

Published:2024-06-19 Issue:1 Volume:35 Page:
ISSN:0953-7104
Container-title:Platelets
language:en
Short-container-title:Platelets

Author:

Dai Wen-Bo¹,Ren Jia-Yi¹,Hu Su-Tao¹,Zhang Yu-Kun¹,Gu Tian-Shu¹,Wu Xue²,Zhang Jing-Kun³,Che Jing-Jin¹,Ma Xiang-Hong¹,Liu Tong¹,Li Guang-Ping¹,Chen Kang-Yin¹

Affiliation:

1. Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China

2. Institute for Global Health Sciences, University of California, San Francisco, USA

3. Cardiovascular Research Institute, University of California, San Francisco, USA

Funder

Key Project of Natural Science Foundation of Tianjin Science and Technology Bureau

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/09537104.2024.2364748

Reference24 articles.

1. 2023 ESC Guidelines for the management of acute coronary syndromes

2. Coronary Artery Disease and Aspirin Intolerance: Background and Insights on Current Management

3. Aspirin and Clopidogrel Resistance

4. Aspirin Use Post-Acute Coronary Syndromes: Intolerance, Bleeding and Discontinuation

5. Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP